Cover Image
市場調查報告書

EpiCast Report:生殖器皰疹的流行病學預測 (到2023年)

EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

出版商 GlobalData 商品編碼 337343
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:生殖器皰疹的流行病學預測 (到2023年) EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023
出版日期: 2015年07月10日 內容資訊: 英文 58 Pages
簡介

生殖器皰疹是慢性的性感染疾病,因單純皰疹病毒 (HSV) 而發病。生殖器皰疹也從母親感染新生兒,感染的嬰兒死亡風險也變高。單純皰疹病毒有HSV-1和HSV-2二種,全球整體HSV-2人患病人數多,不過已開發國家的新發病數量HSV-1變高。全球主要7個國家確診的發病數量,2013年為405,319件,預計2023年達到448,525件,男性發病率略低於女性。

本報告提供全球主要7個國家的生殖器皰疹的發病情形和今後預測相關分析、疾病的特徵(風險要素和主要的共生病症等等)全球各國的趨勢、目前患病者的發病情形、今後10年的發病、患病數量 (性別、各病毒株) 的預測值等調查評估。

第1章 目錄

第2章 簡介

第3章 流行病學

  • 疾病的背景
  • 風險要素和共生病症
  • 全世界的趨勢
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 生殖器皰疹的流行病學預測(今後11年份)
    • 確診的發病數量
    • 各確診的發病數量 (病毒株)
    • 確診的發病數量 (性別)
    • 診斷的第一年確診感染了HSV-1生殖器皰疹的患者數
    • 診斷的第一年確診感染了HSV-2生殖器皰疹的患者數
    • 只確診的患病人數 (HSV-1)
    • 只確診的患病人數 (HSV-2)
    • 併發確診的患病人數 (HSV-1、HSV-2雙方)
  • 討論
    • 流行病學性的預測相關結論
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表一覽

目錄
Product Code: GDHCER084-15

Genital herpes is a chronic, sexually transmitted infection caused by the herpes simplex virus (HSV) and is the primary cause of genital ulcers. Genital herpes can also be vertically transmitted from a mother to her newborn during birth, leading to a high risk of mortality in infants. HSV has two forms: HSV-1 and HSV-2. The majority of genital herpes cases globally are caused by HSV-2, although approximately half of all new cases in developed countries are caused by HSV-1. Most cases of genital herpes are asymptomatic, leading to the diagnosed prevalence being substantially lower than that of the total prevalence. The symptomatic cases of genital herpes are typically characterized by painful blisters on the genitals and surrounding areas, which normally present between four and seven days after sexual contact with another infected individual.

GlobalData epidemiologists forecast an increase in the diagnosed incident cases of genital herpes in the 7MM from 405,319 in 2013 to 448,525 diagnosed incident cases in 2023, at an Annual Growth Rate (AGR) of 1.07% during the forecast period. The distribution of diagnosed incident cases of genital herpes in the 7MM was lower in men (153,129 cases, 37.78% in 2013) than it was in women (252,190 cases, 62.22% in 2013). The diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and HSV-1 and HSV-2 co-infection genital herpes increased from 2013 to 2023 in the 7MM, with respective AGRs of 0.53%, 0.71%, and 0.74%. In all the markets, the diagnosed prevalent cases of genital herpes increased with age, which is reflective of the lifetime infection characteristic of the disease.

GlobalData's epidemiological forecasts for the diagnosed incident cases and diagnosed prevalent cases of genital herpes are supported by age- and sex-specific data obtained from country-specific studies published in peer-reviewed journals, in which the study populations were representative of the general population in the respective markets. The forecast provides the sex-specific diagnosed incident cases of genital herpes in each of the 7MM and the diagnosed prevalent cases of genital herpes segmented by strain type (HSV-1, HSV-2, and the co-infection of HSV-1 and HSV-2), which facilitate an in-depth understanding of the epidemiological trends and informs strategies to improve the management of the disease.

Scope

  • The Genital Herpes EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for genital herpes in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of genital herpes, segmented by strain (HSV-1 and HSV-2) for ages =18 years, and the diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and genital herpes caused by the co-infection of both HSV-1 and HSV-2, segmented by sex for ages =18 years.
  • The Genital Herpes epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Genital Herpes EpiCast series will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global genital herpes market.
  • Quantify patient populations in the global genital herpes market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for genital herpes therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
  • 3.3. Global Trends
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods
  • 3.5. Epidemiological Forecast of Genital Herpes (2013-2023)
    • 3.5.1. Diagnosed Incident Cases of Genital Herpes
    • 3.5.2. Diagnosed Incident Cases of Genital Herpes Segmented by Strain
    • 3.5.3. Diagnosed Incident Cases of Genital Herpes Segmented by Sex
    • 3.5.4. Number of Persons Diagnosed with HSV-1 Genital Herpes Experiencing Recurrences During the First Year of Diagnosis
    • 3.5.5. Number of Persons Diagnosed with HSV-2 Genital Herpes Experiencing Recurrences During the First Year of Diagnosis
    • 3.5.6. Diagnosed Prevalent Cases of HSV-1 Only Genital Herpes
    • 3.5.7. Diagnosed Prevalent Cases of HSV-2 Only Genital Herpes
    • 3.5.8. Diagnosed Prevalent Cases of HSV-1 and HSV-2 Co-infection Genital Herpes
  • 3.6. Discussion
    • 3.6.1. Epidemiological Forecast Insight
    • 3.6.2. Limitations of the Analysis
    • 3.6.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Therapy Analysis and Epidemiology Director of Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for Genital Herpes
  • Table 2: Sources of Epidemiological Data Used for the Forecast of the Diagnosed Incident Cases of Genital Herpes in the 7MM
  • Table 3: Sources of Epidemiological Data Used for the Forecast of the Total Prevalent Cases of HSV-1 Infections in the 7MM
  • Table 4: Sources of Epidemiological Data Used for the Forecast of the Total Prevalent Cases of HSV-2 Genital Herpes in the 7MM
  • Table 5: Sources of Epidemiological Data Used for the Forecast of the Total Prevalent Cases of HSV-1 and HSV-2 Co-infections in the 7MM
  • Table 6: Sources of Epidemiological Data Used for the Forecast of the Diagnosis Rate of HSV-1 Only Genital Herpes in the 7MM
  • Table 7: Sources of Epidemiological Data Used for the Forecast of the Diagnosis Rate of HSV-2 Only Genital Herpes in the 7MM
  • Table 8: Sources of Epidemiological Data Used for the Forecast of the Diagnosis Rate of HSV-1 and HSV-2 Co-infection Genital Herpes in the 7MM
  • Table 9: 7MM, Sources Not Used in the Epidemiological Analysis of Genital Herpes
  • Table 10: 7MM, Diagnosed Incident Cases of Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years 2013-2023
  • Table 11: 7MM, Diagnosed Incident Cases of Genital Herpes Segmented by Strain, Both Sexes, Ages ≥18 Years, 2013
  • Table 12: 7MM, Diagnosed Incident Cases of Genital Herpes Segmented by Sex, Ages ≥18 Years, N (Row %)2013
  • Table 13: 7MM, Number of Persons Diagnosed with HSV-1 Experiencing Recurrences during the First Year of Diagnosis, Both Sexes, Ages ≥18 Years, 2013
  • Table 14: 7MM, Number of Persons Diagnosed with HSV-2 Experiencing Recurrences During the First Year of Diagnosis, Both Sexes, Ages ≥18 Years, 2013
  • Table 15: 7MM, Diagnosed Prevalent Cases of HSV-1 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, Select Years, 2013-2023
  • Table 16: 7MM, Diagnosed Prevalent Cases of HSV-2 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, Select Years, 2013-2023
  • Table 17: 7MM, Diagnosed Prevalent Cases of HSV-1 and HSV-2 Co-infection Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years, 2013-2023

List of Figures

  • Figure 1: 7MM, Diagnosed Incident Cases of Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years, 2013-2023
  • Figure 2: Diagnosed incident Cases of Genital Herpes Segmented by Strain, Both Sexes, Ages ≥18 Years, 2013
  • Figure 3: 7MM, Diagnosed Incident Cases of Genital Herpes Segmented by Sex, Ages ≥18 Years, 2013
  • Figure 4: 7MM, Diagnosed Prevalent Cases of HSV-1 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Figure 5: 7MM, Diagnosed Prevalent Cases of HSV-2 Only Genital Herpes, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Figure 6: 7MM, Diagnosed Prevalent Cases of HSV-1 and HSV-2 Co-infection Genital Herpes, Both Sexes, Ages ≥18 Years, Select Years, 2013-2023
Back to Top